Marieke van der Heiden

Marieke van der Heiden is a Post-doctoral Researcher in Viral Immunology and Vaccination at the University of Groningen's Faculty of Medical Sciences, affiliated with the Translational Immunology Groningen (TRIGR) group. Her research focuses on vaccine responses, immunological aging, and biomarkers in vaccination, particularly in immunocompromised populations such as cancer patients, kidney transplant recipients, and the elderly. She has contributed to studies on SARS-CoV-2 vaccination efficacy, T cell responses in solid tumors, and the impact of age and comorbidities on vaccine outcomes.

Her expertise spans viral immunology, T-cell biology, and translational research. Notable projects include the RECOVAC trial assessing vaccine responses in kidney transplant patients and investigations into inflammageing markers linked to frailty. Collaborations involve multidisciplinary teams addressing immune responses in chronic diseases and infectious threats.

Publications highlight her work on vaccine efficacy, T-cell functionality, and immune profiling in clinical populations. Grants and collaborations are evident through her involvement in randomized controlled trials and epidemiological studies. She leads or co-leads research projects on vaccine immunogenicity and immune correlates of protection, contributing to global efforts in infectious disease prevention.